PHK
WST icon

Point72 Hong Kong’s West Pharmaceutical WST Stock Holding History

Point72 Hong Kong’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-800
Closed -$375K – 2380
2021
Q4 		$375K Sell
800
-500
-38% -$215K 0.01% 850
2021
Q3 		$552K Sell
1,300
-1,300
-50% -$548K 0.02% 902
2021
Q2 		$934K Buy
+2,600
New +$859K 0.03% 735

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Point72 Hong Kong's WST Position: Q3 2025 in Review

Point72 Hong Kong reduced its West Pharmaceutical (WST) stake by 85% in Q3 2025, selling an estimated $1.38M and leaving 1,027 shares worth $269K. The position accounts for 0.01% of the portfolio, ranked #298.

Point72 Hong Kong first reported a position in WST in Q2 2016 and has held it in 18 quarters since. The position peaked at $12.2M in Q4 2023. 757 funds tracked by Wall St. Rank hold WST as of Q3 2025.

  • Point72 Hong Kong held 1,027 shares of West Pharmaceutical worth $269K as of Q3 2025.
  • Point72 Hong Kong sold 5,683 West Pharmaceutical shares in Q3 2025, an estimated $1.38M.
  • West Pharmaceutical made up 0.01% of Point72 Hong Kong's portfolio in Q3 2025, its #298 holding.
  • Point72 Hong Kong first reported a position in West Pharmaceutical in Q2 2016 and has held it in 18 quarters since.
  • Point72 Hong Kong's West Pharmaceutical position peaked at $12.2M in Q4 2023.
  • 757 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2025.

Based on Point72 Hong Kong's 13F filing for Q3 2025, filed 14 Nov 2025.